News

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Shareholders wishing to attend the General Meeting must: Shareholders whose shares are trustee-registered in the name of a bank or other trustee must, to be able to exercise their voting rights at the General Meeting, request the trustee to...

Revenue increased in the second quarter by 18.6 percent to 75.1 MSEK (63.3) after strong growth from both business units. “I am pleased to see the continued strong growth compared to previous year given that the first half year last year was a record period”, comments Torbjörn Sköld. The gross profit amounted to 44.6 percent (45.4). Business unit Surgical Tables was affected...

Revenues increased in the first quarter by 17.5 percent to 72.4 (61.6) after strong growth from both business units. “I am satisfied to see such strong growth compared to previous year given that the first quarter last year was a record quarter”, comments Torbjörn Sköld. The gross profit amounted to 42.4 percent (44.8). Business unit Surgical Tables was affected by an unfavorable...

To participate in the Annual General Meeting, one must be recorded as shareholder in the share register maintained by Euroclear Sweden AB on April 26th, 2023, and no later than April 28th, 2023, at 12.00, to register their participation in the Annual General Meeting to the company. Shareholders who have their shares registered in the name of a nominee must request the nominee to enter the shareholder...

Today, Stille AB publishes the annual report for 2022. The report can be found on the company website www.stille.se. The annual report in its entirety is provided as an attachment to this press release. Torshälla, March 31st, 2023. For more information, please contact: Torbjörn Sköld CEO and President +46 (0)70 316 63 91 | torbjorn.skold@stille.se Stille AB (publ) publ) develops, manufactures...

Revenues increased in the fourth quarter by four percent to 61.8 (59.6) and EBIT increased by 60 percent to 8.8 MSEK (5.5). Profitability was positively affected by currency effects. For the full year 2022, sales grew by 76 percent, out of which 16 percent in organic growth. Operating profit increased to 32.4 MSEK (20.1). In the fourth quarter, business unit Surgical Table sales declined by four percent...

Stille AB reports that Torbjörn Sköld, incoming CEO starting March 20th, 2023, purchased 8,770 shares in Stille on January 31st, 2023. The shares were purchased at 114 SEK per share, with a total value of 997,780 SEK. Torshälla, February 2nd, 2023. For more information, please contact: Niklas Carlén Interim CEO and President +46 (0)73 087 49 70 | niklas.carlen@stille.se Stille...

Torbjörn Sköld will begin his tenure as new Stille’s new CEO on March 20th, 2023, where he will replace Hanna Ernestam Wilkman who has been the company’s CEO since April 1st, 2019. Stille’s board of directors have decided to appoint Niklas Carlén as Interim CEO up until Torbjörn will commence his employment. Niklas has been the company’s CFO since June...

Torbjörn will begin his tenure on March 20th, 2023, where he will replace Hanna Ernestam Wilkman who has been the company’s CEO since April 1st, 2019. Torbjörn comes most recently from De Puy Synthes EMEA, a Johnson & Johnson company, where he has been Vice President. Lars Kvarnhem, chairman of the board comments today’s announcement: “First, I would like to thank Hanna...

Revenues increased by 17 percent to 59.6 MSEK (51.1). Operating profit increased by 32 percent to 7.2 MSEK (5.5). Positive currency effects of 2.7 MSEK affected the result after financial items. Revenues for Surgical Instruments increased by six percent to 30.1 MSEK (28.4). Profitability was affected by an unfavorable product and geographic market mix. Surgical Table-revenues grew by 30 percent to...